| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 20,862 | 23,548 | 25,941 | 23,537 | | Cost of Revenue | 15,530 | 16,517 | 19,812 | 18,155 | | | Gross Profit | 5,332 | 7,031 | 6,129 | 5,382 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 2,929 | 2,958 | 2,715 | 2,863 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 2,470 | 4,073 | 3,414 | 2,519 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (57) | 42 | (5) | (62) | | Earnings Before Interest And Taxes | 2,346 | 4,115 | 3,409 | 2,457 | | Interest Expense | (43) | 14 | 13 | 16 | | Income Before Tax | 2,389 | 4,101 | 3,396 | 2,441 | | Income Tax Expense | 797 | 1,484 | 1,296 | 903 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 1,592 | 2,617 | 2,100 | 1,538 | | | Non-recurring Events | | Discontinued Operations |
-
| (198) | 294 | 92 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 1,592 | 2,419 | 2,394 | 1,630 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $1,592 | $2,419 | $2,394 | $1,630 |
|
0.02% Nasdaq 
Income Statement
